ASX rises as Cettire drops 12pc after disappointing earnings update. Retail house Premier Investments surge after potential Myer deal ...

If you're looking for a long-term investment win, these are the ASX shares our Foolish writers say should be on your ticket right now!

Lastly, we're continuing to expand access to FILSPARI outside of the U.S. with our partners CSL Vifor and Renalys ... Study due to necessary commercial scale up process improvements, we continue ...

BMW says the M4 Competition can return between 9.7 l/100 km (24.2 US mpg) and 9.9 l/100 km (23.7 US mpg) over the combined ...

Appetite/weight gain was reported among the most common ... “Objective improvement, either on the functional scale or the muscle impairment scale — that’s really response treatment.

CSL (AU:CSL) has released an update. CSL Limited is hosting its 2024 Research & Development Investor Briefing, offering investors insights into the company’s latest innovations and strategic ...

CSL was a top pick for Australian share portfolios since its listing in 1994 until valuations fell sharply last year on investor fears that the new generation of weight-loss drugs would reduce the ...

(RTTNews) - At the Annual General Meeting, Paul McKenzie, Chief Executive Officer of CSL Ltd. (CSL.AX), reaffirmed the company's financial guidance for fiscal year 2025. The company still expects ...

Building envelope solutions provider Carlisle Companies (NYSE:CSL) fell short of the market ... built competitive advantages with economies of scale, brand recognition, and strong relationships ...

Shares of building envelope solutions provider Carlisle Companies (NYSE:CSL) fell 8.4% in the morning session after the company reported disappointing third-quarter earnings results. Its revenue ...

Bell Potter highlights that there is a lot to like about CSL. It notes that the company holds the number one and number two positions in its three key markets. These are plasma-derived therapies ...